Message :
Required fields
NEW HAVEN, Conn., April 07, 2021 (GLOBE NEWSWIRE) Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™ (nalbuphine ER) to treat serious neurologically mediated conditions, today announced that management will participate in a virtual fireside chat, as well as host investor meetings, at the 20
th Annual Needham Virtual Healthcare Conference on April 14, 2021. Trevi’s presentation is scheduled for 2:15 p.m. ET.
A live webcast of the virtual fireside chat can be accessed by visiting ‘News & Events’ in the ‘Investors & News’ section on the Company’s website at www.trevitherapeutics.com. An archived replay of the webcast will also be available for 30 days on the Company’s website following the conference.
Share this article
Share this article
SEATTLE, April 7, 2021 /PRNewswire/ CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the 20th Annual Needham Virtual Healthcare Conference at 3:00 p.m. EST. The conference will be held in a virtual meeting format.
Presentation details:
Date: Wednesday, April 14, 2021
Time: 3:00 p.m. EST
The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma s website at www.ctibiopharma.com.
About CTI BioPharma Corp.
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active
Semler to Participate in the 20th Annual Needham Virtual Healthcare Conference
News provided by
Share this article
Share this article
SANTA CLARA, Calif., April 7, 2021 /PRNewswire/ Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian, and chief marketing officer, Dennis Rosenberg, will present a company overview at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13, at 4:30 pm ET. Management will also participate in one-on-one calls with investors.
A live webcast will be available under Events and Presentations on the Investor Info section of the Semler Scientific website and may be accessed through the following link: https://wsw.com/webcast/needham107/smlr/2276780. The presentation will be archived for a period of 90 days after the conference.
CryoLife to Participate in 20th Annual Needham Virtual Healthcare Conference
News provided by
Share this article
Share this article
ATLANTA, April 7, 2021 /PRNewswire/ CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 20
th Annual Needham Virtual Healthcare Conference on Wednesday, April 14, 2021. The Company s virtual fireside chat is scheduled to begin at 8:45 a.m. ET.
A live webcast of the virtual fireside chat will be accessible through CryoLife s website, www.cryolife.com, on the Investor Relations page. An archived copy of the webcast will be available for 90 days on the same website.
NextCure to Present at the 20th Annual Needham Virtual Healthcare Conference benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.